Introduction of Miglito

Miglitol is an articulate anti-diabetic biologic that acts by inhibiting the adeptness of the accommodating to breach down circuitous carbohydrates into glucose. It is primarily acclimated in diabetes mellitus blazon 2 for establishing greater glycemic ascendancy by preventing the assimilation of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be captivated by the body.

Miglitol, and added structurally-related iminosugars, arrest glycoside hydrolase enzymes alleged alpha-glucosidases. Since miglitol works by preventing assimilation of carbohydrates, it lowers the bulk of postprandial hyperglycemia. It accept to be taken at the alpha of capital commons to accept acute effect. Its aftereffect will depend on the bulk of non-monosaccharide carbohydrates in a person's diet.

In adverse to acarbose (another alpha-glucosidase inhibitor), miglitol is systemically absorbed; however, it is not metabolized and is excreted by the kidneys.